Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 5

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 5
---
 or our or their affiliates, will be entitled to reimbursement for any out-of-pocket expenses related
to identifying, investigating and completing an initial business combination. As a result, there may be actual or potential material conflicts
of interest between members of our management team, our initial shareholders, including our sponsor, and our or their respective affiliates
on the one hand, and purchasers in this offering on the other. See “ Summary — Initial Shareholders Information,”
“Summary — The Offering — Founder Shares,” “ Summary — The Offering — Transfer Restrictions on Founder Shares,” “ Summary — The Offering — Founder Shares Conversion and Anti-Dilution Rights” and “ Risk Factors — Risks Relating to our Management Team — The nominal purchase price paid by our initial shareholders for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our initial shareholders are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline” for further discussion on our initial shareholders’ and our affiliates’ securities and compensation.

As more fully discussed in “Management — Conflicts of Interest,” each of our officers and directors presently has, and any of them in the future may have additional,
fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or will
be required to present a business combination opportunity to such entities. The low price that our initial shareholders, officers and
directors (directly or indirectly) paid for the founder shares creates an incentive whereby our initial shareholders, officers and directors
could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable
for public shareholders. If we are unable to complete our initial business combination within the completion window, the founder shares
and private placement warrants may expire worthless, except to the extent they receive liquidating distributions from assets outside the
trust account, which could create an incentive for our initial shareholders, officers and directors to complete a transaction even if
we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Further, each of our
officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or
resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to